News for Sanofi Stock (SNY)

Sanofi plans to spin out its consumer health division

Proactive Investors • 10/27/23

Sanofi to create its own Haleon, Kenvue as its stock price tumbles

Invezz • 10/27/23

Sanofi: considering consumer unit listing from late next year

Reuters • 10/27/23

Press Release: Sanofi Enters Next Chapter of Play to Win Strategy

GlobeNewsWire • 10/27/23

Press Release: Dupixent® (dupilumab) Phase 3 Results show sustained efficacy for up to one year in children 1 to 11 years of age with eosinophilic esophagitis (EoE)

GlobeNewsWire • 10/22/23

Sanofi seeing 'unprecedented' demand for RSV therapy

Reuters • 10/20/23

GoodRx to offer Sanofi's insulin injection for only $35

Reuters • 10/19/23

Sanofi to offer insulin product for $35 to all Americans through GoodRx

CNBC • 10/19/23

GoodRx Announces New Way for Consumers to Access Sanofi's Lantus for $35 at Over 70,000 Pharmacies Nationwide

Business Wire • 10/19/23

Press Release: Sanofi delivers first medicines from Global Health Unit's Impact brand portfolio

GlobeNewsWire • 10/19/23

Press Release: TZIELD® Phase 3 data presented at ISPAD shows potential to slow the progression of Stage 3 type 1 diabetes in newly diagnosed children and adolescents; full data simultaneously published in The NEJM

GlobeNewsWire • 10/18/23

Press Release: Late-breaking amlitelimab Phase 2b data presented at EADV show potential best-in-class profile in atopic dermatitis

GlobeNewsWire • 10/13/23

Sanofi reaps rewards of immunology investment with eczema results

Market Watch • 10/13/23

2 Surefire Stocks That Could Make You Richer

The Motley Fool • 10/11/23

BioMap Establishes a Strategic Collaboration with Sanofi to Co-Develop AI Modules to Accelerate Drug Discovery for Biotherapeutics

Business Wire • 10/10/23

Nobel for mRNA: Which other biotech stocks might be overlooked?

Proactive Investors • 10/06/23

Sanofi (SNY) Stock Outperforms Industry YTD: What's Next?

Zacks Investment Research • 10/05/23

Sanofi (SNY) Signs Deal to Co-Develop Teva's IBD Candidate

Zacks Investment Research • 10/04/23

Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.

Investors Business Daily • 10/04/23

Teva partnership with Sanofi ‘will pay dividends,' analyst says

Market Watch • 10/04/23

Sanofi to co-develop Teva Pharmaceutical's Colitis, Crohn's drug

Reuters • 10/04/23

Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment

Business Wire • 10/04/23

Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment

GlobeNewsWire • 10/04/23

Press Release - Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment

GlobeNewsWire • 10/04/23

Sanofi and Janssen join forces to develop E.coli vaccine, with Sanofi's $175M upfront payment

Fox Business • 10/03/23